Scholarly Index
Katsuhiko Uesaka
Shizuoka Cancer Center; 13,299 total citations; 519 total publications; best world rank #196
Shizuoka Cancer Center
13,299Total citations
519Total publications
53H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Gallbladder and Bile Duct Disorders | Lifetime | 196 | JP 31 | 98.99 |
| Cholangiocarcinoma and Gallbladder Cancer Studies | Lifetime | 258 | JP 55 | 98.80 |
| Pancreatic and Hepatic Oncology Research | Lifetime | 533 | JP 61 | 98.72 |
| Pancreatitis Pathology and Treatment | Lifetime | 630 | JP 87 | 97.41 |
| Pediatric Hepatobiliary Diseases and Treatments | Lifetime | 498 | JP 66 | 97.32 |
| Hepatocellular Carcinoma Treatment and Prognosis | Lifetime | 882 | JP 139 | 97.52 |
| Neuroendocrine Tumor Research Advances | Lifetime | 815 | JP 76 | 97.50 |
| Inflammatory Biomarkers in Disease Prognosis | Lifetime | 444 | JP 83 | 92.92 |
| IgG4-Related and Inflammatory Diseases | Lifetime | 507 | JP 187 | 87.21 |
| Gallbladder and Bile Duct Disorders | 2021-2025 | 205 | JP 40 | 96.02 |
| Cholangiocarcinoma and Gallbladder Cancer Studies | 2021-2025 | 264 | JP 31 | 95.32 |
| Pancreatic and Hepatic Oncology Research | 2021-2025 | 624 | JP 60 | 95.67 |
| Pancreatitis Pathology and Treatment | 2021-2025 | 716 | JP 69 | 89.07 |
| Inflammatory Biomarkers in Disease Prognosis | 2021-2025 | 671 | JP 102 | 77.14 |